Clinical Trials Browser

NCT00006518 2026-06-05

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Lymphoma, Neoplasms, Sarcoma, Kaposi, Virus Diseases, Lymphoma, Primary Effusion

NCT04902443 2026-06-05

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Phase 1 Recruiting

58 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05907759 2026-06-02

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Phase 2 Recruiting

28 enrolled

LymphoidSarcoma

Multi-centric Castleman's Disease, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, Primary Effusion

NCT04303117 2026-06-01

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Phase 1/2 Recruiting

80 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT06375122 2026-06-01

Natural History Study of Kaposi Sarcoma

Recruiting

150 enrolled

Sarcoma

Sarcoma, Kaposi

NCT03300830 2026-05-29

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

Recruiting

280 enrolled

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Castleman Disease, Immunologic Deficiency Syndromes, Sarcoma, Kaposi

NCT07308886 2026-05-08

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Phase 2 Recruiting

55 enrolled

LymphoidSarcoma

Lymphoproliferative Disorders, Sarcoma, Kaposi

NCT04941274 2026-05-05

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Phase 1/2 Recruiting

111 enrolled

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi